Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPension (IS)Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

GE HealthCare Technologies (GEHC) Shares Outstanding (2023 - 2026)

GE HealthCare Technologies filings provide 4 years of Shares Outstanding readings, the most recent being $459.4 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding changed 0.31% to $459.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $459.4 million, a 0.31% change, with the full-year FY2025 number at $458.8 million, changed 0.4% from a year prior.
  • Shares Outstanding hit $459.4 million in Q1 2026 for GE HealthCare Technologies, roughly flat from $458.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $459.4 million in Q1 2026 to a low of $455.0 million in Q1 2023.
  • Median Shares Outstanding over the past 4 years was $457.0 million (2024), compared with a mean of $456.9 million.
  • Biggest five-year swings in Shares Outstanding: grew 0.44% in 2024 and later increased 0.22% in 2025.
  • GE HealthCare Technologies' Shares Outstanding stood at $455.0 million in 2023, then grew by 0.44% to $457.0 million in 2024, then increased by 0.4% to $458.8 million in 2025, then grew by 0.12% to $459.4 million in 2026.
  • The last three reported values for Shares Outstanding were $459.4 million (Q1 2026), $458.8 million (Q4 2025), and $458.6 million (Q3 2025) per Business Quant data.